Heterocyclic Substituted Carbonyl Derivatives And Their Use As Dopamine D3 Receptor Ligands

  • Published: Apr 21, 2009
  • Earliest Priority: Feb 16 2001
  • Family: 13
  • Cited Works: 0
  • Cited by: 0
  • Cites: 1
  • Additional Info: Full text
Abstract

The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D3 receptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine D3 receptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e.g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine D3 receptors.


Claims
CPC Classifications
IPC Classifications

Download Citation


Sign in to the Lens

Feedback